Modeling an anti-amyloid combination therapy for Alzheimer's disease

Science Translational Medicine

Volumn 2, Issue 13, 2010, Pages

  Chow, Vivian W ^a   Savonenko, Alena V ^a   Melnikova, Tatiana ^a   Kim, Hyunsu ^a   Price, Donald L ^a   Li, Tong ^a   Wong, Philip C ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; BETA SECRETASE 1; DIZOCILPINE; GAMMA SECRETASE;

AGED; ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CANCER RISK; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; LIFESPAN; MALE; MAZE TEST; MENTAL TASK; MOUSE; MYELINATION; NEUROPROTECTION; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN TARGETING; SPLENOMEGALY; TASK PERFORMANCE; WORKING MEMORY;

ALZHEIMER DISEASE; AMYLOID; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ASPARTIC ACID ENDOPEPTIDASES; BEHAVIOR, ANIMAL; COMBINED MODALITY THERAPY; GENOTYPE; HUMANS; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, ANIMAL; MODELS, GENETIC; MUTATION;

EID: 77952994785     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3000337     Document Type: Article

References (53)

1. J. Hardy, D. J. Selkoe, The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297, 353-356 (2002).
2. R. E. Tanzi, L. Bertram, Twenty years of the Alzheimer's disease amyloid hypothesis: A genetic perspective. Cell 120, 545-555 (2005).
3. P. C. Wong, H. Cai, D. R. Borchelt, D. L. Price, Genetically engineered mouse models of neurodegenerative diseases. Nat. Neurosci. 5, 633-639 (2002).
4. B. De Strooper, Aph-1, Pen-2, and Nicastrin with Presenilin generate an active γ-Secretase complex. Neuron 38, 9-12 (2003).
5. T. Li, H. Wen, C. Brayton, P. Das, L. A. Smithson, A. Fauq, X. Fan, B. J. Crain, D. L. Price, T. E. Golde, C. G. Eberhart, P. C. Wong, Epidermal growth factor receptor and Notch pathways participate in the tumor suppressor function of γ-secretase. J. Biol. Chem. 282, 32264-32273 (2007).
6. T. Li, H. Wen, C. Brayton, F.M. Laird, G. Ma, S. Peng, L. Placanica, T. C. Wu, B. J. Crain, D. L. Price, C. G. Eberhart, P. C. Wong, Moderate reduction of γ-secretase attenuates amyloid burden and limits mechanism-based liabilities. J. Neurosci. 27, 10849-10859 (2007).
7. X. Hu, C. W. Hicks, W. He, P. Wong, W. B. Macklin, B. D. Trapp, R. Yan, Bace1 modulates myelination in the central and peripheral nervous system. Nat. Neurosci. 9, 1520-1525 (2006).
8. A. V. Savonenko, T. Melnikova, F. M. Laird, K. A. Stewart, D. L. Price, P. C. Wong, Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice. Proc. Natl. Acad. Sci. U.S.A. 105, 5585-5590 (2008).
9. T. Dejaegere, L. Serneels, M. K. Schäfer, J. Van Biervliet, K. Horré, C. Depboylu, D. Alvarez-Fischer, A. Herreman, M. Willem, C. Haass, G. U. Höglinger, R. D'Hooge, B. De Strooper, Deficiency of Aph1B/C-γ-secretase disturbs Nrg1 cleavage and sensorimotor gating that can be reversed with antipsychotic treatment. Proc. Natl. Acad. Sci. U.S.A. 105, 9775-9780 (2008).
10. F. M. Laird, H. Cai, A. V. Savonenko, M. H. Farah, K. He, T. Melnikova, H. Wen, H. C. Chiang, G. Xu, V. E. Koliatsos, D. R. Borchelt, D. L. Price, H. K. Lee, P. C. Wong, BACE1, a major determinant of selective vulnerability of the brain to amyloid-β amyloidogenesis, is essential for cognitive, emotional, and synaptic functions. J. Neurosci. 25, 11693-11709 (2005).
11. M. Ohno, E. A. Sametsky, L. H. Younkin, H. Oakley, S. G. Younkin, M. Citron, R. Vassar, J. F. Disterhoft, BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease. Neuron 41, 27-33 (2004).
12. M. Willem, A. N. Garratt, B. Novak, M. Citron, S. Kaufmann, A. Rittger, B. DeStrooper, P. Saftig, C. Birchmeier, C. Haass, Control of peripheral nerve myelination by the β-secretase BACE1. Science 314, 664-666 (2006).
13. G. T. Wong, D. Manfra, F. M. Poulet, Q. Zhang, H. Josien, T. Bara, L. Engstrom, M. Pinzon-Ortiz, J. S. Fine, H. J. Lee, L. Zhang, G. A. Higgins, E. M. Parker, Chronic treatment with the γ-secretase inhibitor LY-411, 575 inhibits β-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation. J. Biol. Chem. 279, 12876-12882 (2004).
14. J. Milano, J. McKay, C. Dagenais, L. Foster-Brown, F. Pognan, R. Gadient, R. T. Jacobs, A. Zacco, B. Greenberg, P. J. Ciaccio, Modulation of Notch processing by γ-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation. Toxicol. Sci. 82, 341-358 (2004).
15. D. M.Barten, V. L.Guss, J. A. Corsa, A. Loo, S. B.Hansel, M. Zheng, B.Munoz, K. Srinivasan, B.Wang, B. J. Robertson, C. T. Polson, J. Wang, S. B. Roberts, J. P. Hendrick, J. J. Anderson, J. K. Loy, R. Denton, T. A. Verdoorn, D. W. Smith, K. M. Felsenstein, Dynamics of β-amyloid reductions in brain, cerebrospinal fluid, and plasma of β-amyloid precursor protein transgenic mice treated with a γ-secretase inhibitor. J. Pharmacol. Exp. Ther. 312, 635-643 (2005).
16. L. McConlogue, M. Buttini, J. P. Anderson, E. F. Brigham, K. S. Chen, S. B. Freedman, D. Games, K. Johnson-Wood, M. Lee, M. Zeller, W. Liu, R. Motter, S. Sinha, Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synaptic pathology in APP transgenic mice. J. Biol. Chem. 282, 26326-26334 (2007).
17. L. Serneels, J. Van Biervliet, K. Craessaerts, T. Dejaegere, K. Horré, T. Van Houtvin, H. Esselmann, S. Paul, M. K. Schäfer, O. Berezovska, B. T. Hyman, B. Sprangers, R. Sciot, L. Moons, M. Jucker, Z. Yang, P. C.May, E. Karran, J.Wiltfang, R. D'Hooge, B. De Strooper, γ-Secretase heterogeneity in the Aph1 subunit: Relevance for Alzheimer's disease. Science 324, 639-642 (2009).
18. H. Cai, Y. Wang, D. McCarthy, H. Wen, D. R. Borchelt, D. L. Price, P. C. Wong, BACE1 is the major β-secretase for generation of Aβ peptides by neurons. Nat. Neurosci. 4, 233-234 (2001).
19. G. Ma, T. Li, D. L. Price, P. C. Wong, APH-1a is the principal mammalian APH-1 isoform present in γ-secretase complexes during embryonic development. J. Neurosci. 25, 192-198 (2005).
20. J. L. Jankowsky, L. H. Younkin, V. Gonzales, D. J. Fadale, H. H. Slunt, H. A. Lester, S. G. Younkin, D. R. Borchelt, Rodent Aβ modulates the solubility and distribution of amyloid deposits in transgenic mice. J. Biol. Chem. 282, 22707-22720 (2007).
21. D. R. Borchelt, T. Ratovitski, J. van Lare, M. K. Lee, V. Gonzales, N. A. Jenkins, N. G. Copeland, D. L. Price, S. S. Sisodia, Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19, 939-945 (1997).
22. A. Savonenko, G. M. Xu, T. Melnikova, J. L. Morton, V. Gonzales, M. P. Wong, D. L. Price, F. Tang, A. L. Markowska, D. R. Borchelt, Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: Relationships to β-amyloid deposition and neurotransmitter abnormalities. Neurobiol. Dis. 18, 602-617 (2005).
23. K. I. Andreasson, A. Savonenko, S. Vidensky, J. J. Goellner, Y. Zhang, A. Shaffer, W. E. Kaufmann, P. F. Worley, P. Isakson, A. L. Markowska, Age-dependent cognitive deficits and neuronal apoptosis in cyclooxygenase-2 transgenic mice. J. Neurosci. 21, 8198-8209 (2001).
24. B. Pouzet, W. N. Zhang, J. Feldon, J. N. Rawlins, Hippocampal lesioned rats are able to learn a spatial position using non-spatial strategies. Behav. Brain Res. 133, 279-291 (2002).
25. A. L. Markowska, J. M. Long, C. T. Johnson, D. S. Olton, Variable-interval probe test as a tool for repeated measurements of spatial memory in the water maze. Behav. Neurosci. 107, 627-632 (1993).
26. J. Chen, B. K. Lipska, D. R. Weinberger, Genetic mouse models of schizophrenia: From hypothesis-based to susceptibility gene-based models. Biol. Psychiatry 59, 1180-1188 (2006).
27. A. Buonanno, G. D. Fischbach, Neuregulin and ErbB receptor signaling pathways in the nervous system. Curr. Opin. Neurobiol. 11, 287-296 (2001).
28. J. Bao, D. Wolpowitz, L. W. Role, D. A. Talmage, Back signaling by the Nrg-1 intracellular domain. J. Cell Biol. 161, 1133-1141 (2003).
29. R. Lalonde, The neurobiological basis of spontaneous alternation. Neurosci. Biobehav. Rev. 26, 91-104 (2002).
30. R. G. Lister, The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92, 180-185 (1987).
31. D. C. Javitt, S. R. Zukin, Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry 148, 1301-1308 (1991).
32. L. Leumann, J. Feldon, F. X. Vollenweider, K. Ludewig, Effects of typical and atypical antipsychotics on prepulse inhibition and latent inhibition in chronic schizophrenia. Biol. Psychiatry 52, 729-739 (2002).
33. D. J. Selkoe, Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior. Behav. Brain Res. 192, 106-113 (2008).
34. M. P. Lambert, A. K. Barlow, B. A. Chromy, C. Edwards, R. Freed, M. Liosatos, T. E. Morgan, I. Rozovsky, B. Trommer, K. L. Viola, P. Wals, C. Zhang, C. E. Finch, G. A. Krafft, W. L. Klein, Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U.S.A. 95, 6448-6453 (1998).
35. J. P. Cleary, D. M. Walsh, J. J. Hofmeister, G. M. Shankar, M. A. Kuskowski, D. J. Selkoe, K. H. Ashe, Natural oligomers of the amyloid-β protein specifically disrupt cognitive function. Nat. Neurosci. 8, 79-84 (2005).
36. E. Tamagno, M. Guglielmotto, M. Aragno, R. Borghi, R. Autelli, L. Giliberto, G. Muraca, O. Danni, X. Zhu, M. A. Smith, G. Perry, D. G. Jo, M. P. Mattson, M. Tabaton, Oxidative stress activates a positive feedback between the γ- and β-secretase cleavages of the β-amyloid precursor protein. J. Neurochem. 104, 683-695 (2008).
37. H. Hsieh, J. Boehm, C. Sato, T. Iwatsubo, T. Tomita, S. Sisodia, R. Malinow, AMPAR removal underlies Aβ-induced synaptic depression and dendritic spine loss. Neuron 52, 831-843 (2006).
38. A. Garcia-Osta, C. M. Alberini, Amyloid β mediates memory formation. Learn. Mem. 16, 267-272 (2009).
39. D. Puzzo, L. Privitera, E. Leznik, M. Fà, A. Staniszewski, A. Palmeri, O. Arancio, Picomolar amyloid-β positively modulates synaptic plasticity and memory in hippocampus. J. Neurosci. 28, 14537-14545 (2008).
40. T. Wisniewski, U. Konietzko, Amyloid-β immunisation for Alzheimer's disease. Lancet Neurol. 7, 805-811 (2008).
41. F. M. Laird, H. Cai, A. V. Savonenko, M. H. Farah, K. He, T. Melnikova, H. Wen, H. C. Chiang, G. Xu, V. E. Koliatsos, D. R. Borchelt, D. L. Price, H. K. Lee, P. C. Wong, BACE1, a major determinant of selective vulnerability of the brain to amyloid-β amyloidogenesis, is essential for cognitive, emotional, and synaptic functions. J. Neurosci. 25, 11693-11709 (2005).
42. H. Cai, Y. Wang, D. McCarthy, H. Wen, D. R. Borchelt, D. L. Price, P. C. Wong, BACE1 is the major β-secretase for generation of Aβ peptides by neurons. Nat. Neurosci. 4, 233-234 (2001).
43. G. Ma, T. Li, D. L. Price, P. C. Wong, APH-1a is the principal mammalian APH-1 isoform present in γ-secretase complexes during embryonic development. J. Neurosci. 25, 192-198 (2005).
44. J. L. Jankowsky, D. J. Fadale, J. Anderson, G. M. Xu, V. Gonzales, N. A. Jenkins, N. G. Copeland, M. K. Lee, L. H. Younkin, S. L. Wagner, S. G. Younkin, D. R. Borchelt, Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: Evidence for augmentation of a 42-specific γ secretase. Hum. Mol. Genet. 13, 159-170 (2004).
45. J. L. Jankowsky, L. H. Younkin, V. Gonzales, D. J. Fadale, H. H. Slunt, H. A. Lester, S. G. Younkin, D. R. Borchelt, Rodent Aβ modulates the solubility and distribution of amyloid deposits in transgenic mice. J. Biol. Chem. 282, 22707-22720 (2007).
46. A. K. Vehmas, D. R. Borchelt, D. L. Price, D. McCarthy, M. Wills-Karp, M. J. Peper, G. Rudow, J. Luyinbazi, L. T. Siew, J. C. Troncoso, β-Amyloid peptide vaccination results in marked changes in serum and brain Aβ levels in APPswe/PS1ΔE9 mice, as detected by SELDI-TOF-based ProteinChip technology. DNA Cell Biol. 20, 713-721 (2001).
47. X. Hu, C. W. Hicks, W. He, P. Wong, W. B. Macklin, B. D. Trapp, R. Yan, Bace1 modulates myelination in the central and peripheral nervous system. Nat. Neurosci. 9, 1520-1525 (2006).
48. J. Cohen, A power primer. Psychol. Bull. 112, 155-159 (1992).
49. SWE. Neurobiol. Dis. 12, 194-211 (2003).
50. D. J. McFarland, Effects of scopolamine, δ-amphetamine, and apomorphine on alternation and position biases. Pharmacol. Biochem. Behav. 32, 723-726 (1989).
51. W. Koek, J. H. Woods, G. D. Winger, MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. J. Pharmacol. Exp. Ther. 245, 969-974 (1988).
52. J. Wu, H. Zou, J. A. Strong, J. Yu, X. Zhou, Q. Xie, G. Zhao, M. Jin, L. Yu, Bimodal effects of MK-801 on locomotion and stereotypy in C57BL/6 mice. Psychopharmacology 177, 256-263 (2005).
53. A. L. Markowska, J. M. Long, C. T. Johnson, D. S. Olton, Variable-interval probe test as a tool for repeated measurements of spatial memory in the water maze. Behav. Neurosci. 107, 627-632 (1993).